Martin Treder
Fundador en LTZ Therapeutics, Inc. .
Cargos activos de Martin Treder
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
LTZ Therapeutics, Inc.
 LTZ Therapeutics, Inc. BiotechnologyHealth Technology LTZ Therapeutics, Inc. is an American immunotherapy-focused biotech company that develops novel therapies. The company was founded by Jianhui Zhou, Robert Li, and Martin Treder, with Robert Li serving as the CEO since incorporation. | Director Técnico/Científico/I+D | - | - |
| Fundador | - | - |
Historial de carrera de Martin Treder
Antiguos cargos conocidos de Martin Treder.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AFFIMED N.V. | Director Técnico/Científico/I+D | 01/01/2015 | 22/05/2019 |
CT Atlantic Ltd.
 CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services CT Atlantic AG focuses on the identification and development of human-derived monoclonal antibodies as novel therapeutics for the treatment of cancer. The company was founded by Alexander Knuth, Christoph Esslinger and Edward Stuart in 2008 and is headquartered in Schlieren, Switzerland. | Director Técnico/Científico/I+D | 17/09/2009 | 01/12/2014 |
| Fundador | 17/09/2009 | 01/12/2014 | |
U3 Pharma AG
 U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany. | Director Técnico/Científico/I+D | 01/01/2002 | 01/01/2002 |
| Fundador | 01/10/2001 | 01/10/2008 |
Formación de Martin Treder.
| Monash University | Undergraduate Degree |
| Technische Universität München | Doctorate Degree |
Estadísticas
Internacional
| Alemania | 4 |
| Australia | 2 |
| Suiza | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AFFIMED N.V. | Health Technology |
| Empresas privadas | 3 |
|---|---|
U3 Pharma AG
U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany. | Commercial Services |
CT Atlantic Ltd.
CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services CT Atlantic AG focuses on the identification and development of human-derived monoclonal antibodies as novel therapeutics for the treatment of cancer. The company was founded by Alexander Knuth, Christoph Esslinger and Edward Stuart in 2008 and is headquartered in Schlieren, Switzerland. | Commercial Services |
LTZ Therapeutics, Inc.
LTZ Therapeutics, Inc. BiotechnologyHealth Technology LTZ Therapeutics, Inc. is an American immunotherapy-focused biotech company that develops novel therapies. The company was founded by Jianhui Zhou, Robert Li, and Martin Treder, with Robert Li serving as the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Martin Treder
- Experiencia
